AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 16 analysts
Fundamentals
Fundamentals institutional score is 86 using growth durability 86.0.
Valuation
Valuation institutional score is 34 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 27 using mean target upside -9.3%; dispersion penalty 18.2; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 18 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 1 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. fundamentals provide support, while valuation and analyst consensus remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 28.6% above historical median. Valuation is stable — currently in the strongly overvalued zone (z-score: +1.38). Confidence: 80%.
Live forward EPS implies next-12-month EPS of ₹18.52. Applying the stock's normalized valuation corridor produces a fair range of ₹560.04 to ₹718.58, with base value near ₹640.61 (+32.5% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹18.52
Forward P/E
26.1x
Base Fair Value
₹640.61
Fair Range
₹560.04 - ₹718.58
Upside To Base
+32.5%
Estimate Source
Live forward EPS
Growth Estimate
+28.3%
5Y Average
27.65
Current
44.47
Overvalued
38.80
Undervalued
30.24
5Y Average
13.40
Current
21.55
Overvalued
17.12
Undervalued
7.74
5Y Average
1.36
Current
2.18
Overvalued
1.56
Undervalued
1.15
Peers & Comparison
Sector: Industrials · Theme: Batteries
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
DABUR INDIA LTD DABURFMCG - Personal Products | +10.6% | 14.6% | 36.8x Undervalued | -72% vs avg | -17.6% |
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 30.7x Undervalued | -76% vs avg | -5.0% |
CG POWER AND IND SOL LTD CGPOWERHeavy Electrical Equipments | +14.0% | 9.8% | 111.4x Fair | -14% vs avg | +32.2% |
MAX FINANCIAL SERV LTD MFSLInsurance | -40.2% | 0.2% | 624.6x Premium | +382% vs avg | -5.7% |
HERO MOTOCORP LIMITED HEROMOTOCOTwo Wheelers | +34.9% | 10.7% | 21.1x Undervalued | -84% vs avg | +26.2% |
BSE LIMITED BSEStock Exchanges & Ratings | +64.0% | 48.9% | 50.4x Undervalued | -61% vs avg | +50.1% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 65.1x Undervalued | -50% vs avg | +23.2% |
BHARAT FORGE LTD BHARATFORGIron & Steel | +17.5% | 6.4% | 97.7x Undervalued | -25% vs avg | +81.6% |
EXIDE INDUSTRIES LTD trades at a discount (44.6x vs peer avg 129.7x), suggesting potential undervaluation relative to the Batteries cohort. Peers include DABUR INDIA LTD, DR. REDDY S LABORATORIES, CG POWER AND IND SOL LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹5.30K CrJun 2026Latest net profit
₹407 CrJun 2026Latest EPS
₹4.79Jun 2026Net margin
12.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 4,073 | 4,107 | 3,841 | 4,009 | 4,313 | 4,267 | 3,849 | 4,159 | 4,510 | 4,178 | 4,030 | 4,551 | 5,305 |
| Expenses + | 3,640 | 3,624 | 3,401 | 3,493 | 3,818 | 3,784 | 3,400 | 3,693 | 3,962 | 3,784 | 3,560 | 4,021 | 4,650 |
| Operating Profit | 432 | 483 | 440 | 516 | 494 | 484 | 449 | 467 | 548 | 395 | 470 | 530 | 655 |
| OPM % | 11% | 12% | 11% | 13% | 11% | 11% | 12% | 11% | 12% | 9% | 12% | 12% | 12% |
| Other Income + | 19 | 39 | 23 | 3 | 14 | 53 | 13 | 16 | 18 | 42 | 9 | 14 | 14 |
| Interest | 10 | 12 | 14 | 13 | 9 | 10 | 12 | 13 | 9 | 9 | 8 | 8 | 8 |
| Depreciation | 119 | 126 | 127 | 125 | 126 | 127 | 124 | 127 | 128 | 131 | 127 | 116 | 118 |
| Profit before tax | 322 | 385 | 321 | 382 | 374 | 399 | 325 | 343 | 430 | 298 | 343 | 420 | 543 |
| Tax % | 25% | 25% | 25% | 26% | 25% | 25% | 25% | 26% | 25% | 26% | 25% | 26% | 25% |
| Net Profit + | 242 | 287 | 240 | 284 | 280 | 298 | 245 | 255 | 320 | 221 | 258 | 312 | 407 |
| EPS in Rs | 2.85 | 3.38 | 2.83 | 3.34 | 3.29 | 3.50 | 2.88 | 3.00 | 3.77 | 2.60 | 3.03 | 3.68 | 4.79 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome